Biopharmaceutical companies aim to make taking a biologic drug as simple as possible for patients, marketing many of these chronically administered medicines in self-injection pens for quick and easy dosing. …
Category:
Health
-
-
This month, Cigna announced during its first quarter earnings call that it is exiting its individual exchange business or the Obamacare exchanges at the end of the year, affecting 369,000 …
-
Every year, seasonal pressures stretch hospital capacity to its limits. Periods of increased admissions often force hospitals to postpone elective surgeries as staff and resources are diverted to more urgent …
-
Healthcare didn’t set out to digitize dysfunction. Five decades ago, digital transformation started with optimism and a compelling promise of less friction, more efficiency, and better care. As clinicians and …
-
Health
Can Precision Psychiatry Be Delivered Remotely? The Limits and Opportunities of Telehealth in Interventional Care
The promise of precision psychiatry has never been more tangible. New developments in neuromodulation, including MRI-guided TMS and accelerated theta-burst protocols, are moving mental health care beyond one-size-fits-all treatment and …
-
Today’s healthcare leaders are largely being sold “AI-as-a-service”: SaaS products that solve a specific task and connect to other SaaS products, enhanced with AI, as a wave of startups pushes …
-
For many tertiary care hospitals, not offering extracorporeal membrane oxygenation (ECMO) is increasingly difficult to justify. Choosing not to offer ECMO means patients who could survive are instead transferred, delayed, …
-
Anomaly Insights, an AI-powered payer intelligence company, announced Wednesday that it raised $17 million in funding. The company’s platform analyzes healthcare transactions to identify payer behavior patterns, policy changes and …
-
IKS Health, a Dallas-based company that sells software to healthcare providers, acquired ARAI this week to deepen its agentic AI infrastructure and decrease its reliance on third-party AI models. The …
-
An Aardvark Therapeutics clinical trial that has been on voluntary pause for nearly three months due to a safety signal is now formally under an FDA clinical hold, and the …